ADPT Competitors & Alternatives
Compare Adaptive Biotechnologies Corp with similar stocks in the same industry
Diagnostics & Research
ADPT
Main Stock$22.57
Tradestie Score
59
Market Cap
$2.22B
Revenue Growth
0.4%
Analyst Upside
+5.7%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLLN
BLLN
|
$138.60
|
$6.42B | 244.9 | 54 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$63.78
|
$6.00B | - | 49 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.86
|
$4.60B | 42.5 | 54 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$65.11
|
$3.26B | - | 63 | Compare |
|
VCYT
Veracyte, Inc.
|
$46.32
|
$2.85B | 51.6 | 51 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$25.52
|
$2.44B | - | 48 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$68.56
|
$2.24B | - | 51 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$91.55
|
$1.77B | - | 54 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$47.27
|
$1.54B | - | 52 | Compare |
|
NEOG
Neogen Corp
|
$12.04
|
$1.26B | - | 58 | Compare |
More ADPT Analysis
Data updated: Aug 02, 2026 | Industry: Diagnostics & Research (SIC 2836)
37 stocks in this industry